New York, May 13, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Neurostimulation Devices Global Market Report 2022” – https://www.reportlinker.com/p06277223/?utm_source=GNW
The global neurostimulation devices market is expected to grow from $5.07 billion in 2021 to $5.74 billion in 2022 at a compound annual growth rate (CAGR) of 13.3%. The market is expected to grow to $9 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%.
The neurostimulation devices market consists of sales of surgically or externally placed neurostimulators and related services. The neurostimulation devices are designed to deliver electrical stimulation to specific parts of the patient’s brain, spinal cord, or peripheral nervous system for the treatment of various conditions such as chronic pain, movement disorders, epilepsy, and Parkinson’s disease.
The main products of the neurostimulation devices are implantable devices and external devices.The implantable devices involved are cochlear implants, deep brain stimulation; spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electric stimulation and the external devices are transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS).
The various applications of implantable devices are pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, and Parkinson’s disease that are used by various end-users such as hospitals, rehabilitation centers, and medical clinics.
North America was the largest region in the neurostimulation devices market in 2021.Asia Pacific was the second-largest region in the neurostimulation devices market.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The rising geriatric population across the globe is driving the growth of the neurostimulation device market.An…